atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and...
Addiction
Trevena Reports Third Quarter 2023 Results and Provides Business Update
Company previously announced statistically significant topline TRV045 data from two proof-of-concept studies evaluating S1PR mechanism of action and CNS target...
Sibannac, Inc. Gearing up for Revenue Through Its White-Label Manufacturing, Wholesale Distribution and Opening of Its First Retail Location
Scottsdale, Arizona--(Newsfile Corp. - November 13, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Awakn Life Sciences Announces Receipt of Notice of Non-Compliance with Cboe Exchange Continued Listing Requirements
Toronto, Ontario--(Newsfile Corp. - November 10, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a...
Gambit Recovery Paves the Way for Renewed Hope for Those Struggling with Addiction
GILBERT, AZ / ACCESSWIRE / November 9, 2023 / Gambit Recovery, a leading sober living company, is revolutionizing the approach...
Kollab Youth Partners With Mental Health Technologies
Collaborating in Providing Mental Health Testing for Under-Resourced Middle and High School StudentsAURORA, IL / ACCESSWIRE / November 9, 2023...
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
Additional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breeding CapabilitiesBUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) --...
Protagenic Therapeutics Announces Date of Annual Shareholder Meeting
NEW YORK, NY / ACCESSWIRE / October 13, 2023 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing...
Bicycle Health Partners with Override Health to Establish Patient Referral Relationship, Increasing Access to Specialists in Chronic Pain Care and Opioid Use Disorder Treatment
More than one-in-five patients seeking treatment for chronic pain are prescribed opioids at their initial visit, contributing to an opioid...
Bicycle Health Commends U.S. Drug Enforcement Administration as It Extends Telemedicine Rule Through the End of 2024
This decision will continue to protect thousands of patients across the U.S. who access care for opioid use disorder via...
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0)...
Netsmart Advances Substance Use Disorder Solution Offerings Through Acquisition of Netalytics
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Acquisition--Netsmart today announced the acquisition of Netalytics, a South Carolina-based addiction treatment software and practice management company,...
Küleon Bioscience Announces Scientific Breakthrough with First Known ”Trifunctional” 5-HT2C Receptor Agonist that is also a Full Antagonist of the 5-HT2A and 5-HT2B Receptors, Creating an Exciting Lead for Multiple Neuropsychiatric Illnesses
SEATTLE, WA and IRVINE, CA / ACCESSWIRE / October 5, 2023 / Küleon LLC, a private biotechnology company that has...
Florida’s South Beach Detox Offers a Secure Setting for Medical Detox and Mental Health Care
Patients at South Beach Detox have access to safe and controlled medical detox services, as well as professional support for...
Awakn Life Sciences Completes MDMA Zydis(R) ODT Feasibility Study
Study Confirms MDMA Is Stable on Zydis(R) ODT and Suitable for Pre-Gastric AbsorptionToronto, Ontario--(Newsfile Corp. - October 4, 2023) -...
Inservice Foundation Hosts Annual Fundraising Gala to Celebrate National Recovery Month
NEW YORK, NY / ACCESSWIRE / October 3, 2023 / In honor of National Recovery Month, Inservice Foundation is excited...
Tonix Pharmaceuticals Announces Pricing of $4.5 Million Public Offering
CHATHAM, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical...
Tonix Pharmaceuticals Announces Proposed Public Offering
CHATHAM, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical...
Ibogaine Clinic and Research Center Ensure Safety Protocol of Ibogaine Hydrochloride.
MIAMI, FL / ACCESSWIRE / September 28, 2023 / Located in Playa Del Carmen, Mexico, David Dardashti owns and operates...
Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder
Pre-registration for the LinkedIn Live event will begin on Thursday, September 28th Industry experts to discuss the need for non-abstinence-based...